New stent strategy could cut bleeding risk without raising clot danger

This study looks at a new approach for people with acute coronary syndrome who have both high risk of blood clots and high risk of bleeding. After getting a special drug-coated stent, some patients will take blood thinners for only one month instead of the usual 12 months. The goal is to see if this shorter treatment reduces serious bleeding while still preventing heart attacks and strokes. About 468 adults will take part and be followed for one year.